Research
Apr 23, 2009
In-beam PET reveals proton-beam precision
The superior dose-depth profile that makes proton therapy so beneficial also makes the technique extremely sensitive to uncertainties such as beam-delivery or patient set-up errors. As such, methods for in-vivo monitoring and quality control are in great demand, particularly for use in fractionated proton therapy regimes. One application garnering much interest is PET dosimetry: verifying the proton beam path by measuring the positron-emitting isotopes generated in the patient during treatment.
We hope you've enjoyed the short summary of this article.
To continue reading, and for unlimited access to all content on this site
you will need to complete a short sign-up process.
It's free of charge, and will only take a couple of minutes of your time.
If you've signed up before, simply sign in below.
0 comments